Overall rank by patents
#18,357
Across all tracked assignees
USPTO PatentsView assignee record - 15 granted patents across 3 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A63G (MERRY-GO-ROUNDS; SWINGS; ROCKING-HORSES; CHUTES; SWITCHBACKS; SIMILAR DEVICES FOR PUBLIC AMUSEMENT).
The verdict
Antonio holds 15 US patents across 3 technology areas, rank #18,357 of 50,000 tracked assignees.
Antonio Zamperla S.p.a. has been granted 15 US utility patents between 2016 and 2023, placing Antonio Zamperla S.p.a. at rank #18,357 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A63G (MERRY-GO-ROUNDS; SWINGS; ROCKING-HORSES; CHUTES; SWITCHBACKS; SIMILAR DEVICES FOR PUBLIC AMUSEMENT). As a Foreign Corporation, Antonio Zamperla S.p.a. is one of the more focused assignees in the PatentsView dataset. By volume, Antonio sits between Anchor Orthopedics XT Inc. (15 patents, rank #18,353) and Aranz Healthcare Limited (15 patents, rank #18,361) - the closest US assignees by grant volume. The composite Innovation Score of 27.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 10 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Antonio Zamperla S.p.a.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Antonio Zamperla S.p.a. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ANCHOR ORTHOPEDICS XT INC.
15 patents
ANDE Corporation
15 patents
ANKOBOT (SHANGHAI) SMART TECHNOLOGIES CO., LTD.
15 patents
ANTAYA TECHNOLOGIES CORPORATION
15 patents
APKUDO, INC.
15 patents
APN Health, LLC
15 patents
AQUA MEMBRANES, INC.
15 patents
ARANZ HEALTHCARE LIMITED
15 patents
ANTONIO ZAMPERLA S.p.A.
15 patents
What this shows Antonio holds 15 patents at rank #18,357, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #18,357 in granted patent volume.
Other assignees with the most granted patents in Antonio's primary technology class.
Antonio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 76% higher than 24% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 6.7% |
| 2017 | 1 | 6.7% |
| 2018 | 5 | 33.3% |
| 2019 | 3 | 20.0% |
| 2020 | 2 | 13.3% |
| 2021 | 1 | 6.7% |
| 2022 | 1 | 6.7% |
| 2023 | 1 | 6.7% |
Top 3 of 3 technology areas
Overall rank by patents
#18,357
Across all tracked assignees
27.6 out of 100
How to use this portfolio
Antonio's 15 grants land it in the top 76% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.